Lightnews — Scholar-powered news

ESGVH (ESCMID Study Group for Viral Hepatitis) @esgvh.bsky.social · 27d

Inspiring session at the ESCMID #VaccinesConference! 🌍

This morning's hepatitis elimination session featured expertly delivered presentations from @esgvh.bsky.social members @oana-sandulescu.bsky.social, Susanne Dudman, Zeinab Nabil, and Mario Mondelli. An insightful morning 👏

@escmid.bsky.social

1

Reposted by ESGVH (ESCMID Study Group for Viral Hepatitis)

Oana Sandulescu @oana-sandulescu.bsky.social · 27d

✨ Day 3 at @escmid.bsky.social #VaccinesConference

Now up 👉 Eliminating Hepatitis by 2030: How Vaccines are Key to Achieving WHO’s Vision?

Fascinating fresh perspectives from international experts 🌍

Honored to join this outstanding panel and contribute to a thought-provoking conversation 🙌✨

1 1 1

Reposted by ESGVH (ESCMID Study Group for Viral Hepatitis)

ESCMID @escmid.bsky.social · 28d

Break time is networking time at the #VaccinesConference! Day 2 kicked off with a session on #vaccines against gastrointestinal infections and some great abstract presentations. Now attendees can enjoy a short break before the next set of sessions start focused on #OneHealth. #IDsky

1 1 2

Reposted by ESGVH (ESCMID Study Group for Viral Hepatitis)

ESCMID @escmid.bsky.social · 28d

Fantastic session on vaccine licensing covering aspects from fighting ongoing outbreaks, limited clinical data, and the current latest developments in the pipeline. Featuring Marco Cavaleri, Sarah Gilbert, Teresa Lambe and Annelies Wilder-Smith.
@ema.europa.eu #VaccinesConference #Vaccines #IDSky

3 4

Reposted by ESGVH (ESCMID Study Group for Viral Hepatitis)

Oana Sandulescu @oana-sandulescu.bsky.social · 27d

Delighted to have chaired this session at the #VaccinesConference by @escmid.bsky.social

Covering updates in CMV, RSV, and pertussis, the take home message is: Use the vaccines we have and foster research for future developments in vaccinology. 💉🔬

Now up, a thought provoking keynote lecture.

1 1

Reposted by ESGVH (ESCMID Study Group for Viral Hepatitis)

Oana Sandulescu @oana-sandulescu.bsky.social · Jul 30

A pleasure to be part of the scientific committee for this event.

Make sure to join us in Bucharest on 5-6 Nov and submit your abstracts by 19 Sep to showcase your research.

amededu.co/45sJDE0

1 2

Reposted by ESGVH (ESCMID Study Group for Viral Hepatitis)

World Hepatitis Alliance @worldhepalliance.bsky.social · Jul 28

Today is #WorldHepatitisDay!

Let's break down all the obstacles hindering the elimination of viral hepatitis.

Read our president's address!

www.worldhepatitisalliance.org/news/world-h...

6 5

Reposted by ESGVH (ESCMID Study Group for Viral Hepatitis)

Philippa Matthews @pippa-matt.bsky.social · Jul 28

Research is crucial to inform better interventions for #diagnosis, #prevention & #treatment of viral #hepatitis for different people in different settings. Global collaboration essential!
#WorldHepatitisDay #NoHep #HBV
@crick.ac.uk @ahri-news.bsky.social @cnwl.nhs.uk @ucllifesciences.bsky.social
🧪

1 6 23

ESGVH (ESCMID Study Group for Viral Hepatitis) @esgvh.bsky.social · Jul 28

🟡Today is #WorldHepatitisDay

@esgvh.bsky.social stands for stigma-free equitable access to viral hepatitis testing & treatment.

🎥Missed our webinar with @ecdc.europa.eu, @whoeurope.bsky.social & @worldhepalliance.bsky.social?
👉Replay now: lnkd.in/dmJKN85U

#Hepatitis #WHD2025
@escmid.bsky.social

This link will take you to a page that’s not on LinkedIn

lnkd.in

2 3

ESGVH (ESCMID Study Group for Viral Hepatitis) @esgvh.bsky.social · Jul 18

📢 Call to young researchers:

On behalf of the @esgvh.bsky.social Publication Subcommittee, Prof Zeinab Nabil is assessing challenges for early-career CM and ID physicians in research.

If you are an early career MD, fill out the survey below:

lnkd.in/dkQbmWqQ

@escmid.bsky.social

This link will take you to a page that’s not on LinkedIn

lnkd.in

1 1

Reposted by ESGVH (ESCMID Study Group for Viral Hepatitis)

Oana Sandulescu @oana-sandulescu.bsky.social · Jul 11

🚨 Call for Papers!

Extra Baggage: Preparing the Traveler with Medical Comorbidities 🌍✈️

Collection in Tropical Diseases, Travel Medicine & Vaccines (IF 2.2)

Submit you work on chronic illness, travel prep, vaccines, & more.

📩 Info: bit.ly/3EBo9Kw

#TravelMedicine

@springernature.com

1 2

ESGVH (ESCMID Study Group for Viral Hepatitis) @esgvh.bsky.social · Jul 3

@ecdc.europa.eu @worldhepalliance.bsky.social @escmid.bsky.social

1

ESGVH (ESCMID Study Group for Viral Hepatitis) @esgvh.bsky.social · Jul 3

🚨 Today!
💡 High-level webinar
📢 World Hepatitis Day 2025 – Viral hepatitis cannot wait!
Join a milestone event co-organized by:
🔹 ESGVH
🔹 ECDC
🔹 WHO Europe
🔹 WHA
📅 Today, 3 July 2025
🕚 11:00–12:00 CET

🔗 Register now:
lnkd.in/dUipyqcp

@esgvh.bsky.social @oana-sandulescu.bsky.social

1 2

Reposted by ESGVH (ESCMID Study Group for Viral Hepatitis)

European AIDS Clinical Society @eacsociety.bsky.social · Jun 30

We are at the @europarl.europa.eu for the EP Roundtable hosted by MEP @krzysztofsmiszek.bsky.social

Today's discussions bring together policymakers, clinicians, researchers & community voices to address persistent barriers in the #HIV response and shape a united way forward.

2 2

Reposted by ESGVH (ESCMID Study Group for Viral Hepatitis)

ESCMID @escmid.bsky.social · Jun 20

The Emerging Infections Subcommittee launches ESCMID-AUMC Epi Alert! Aiming for weekly publication, these reports aim to provide summaries on emerging infections for busy healthcare professionals w/ direct links for further investigation & transparency. ow.ly/5Rrj50WcejS

#IDSky #clinmicro

1 4 3

Reposted by ESGVH (ESCMID Study Group for Viral Hepatitis)

EASL @easlnews.bsky.social · Jun 24

Help shape #EASLCongress 2026! We’re gathering input from the hepatology community to build a relevant, inclusive, and impactful programme. Share your insights in our short survey + enter to win free registration. 👉 www.surveymonkey.com/r/6F9BRBD

1 1

Reposted by ESGVH (ESCMID Study Group for Viral Hepatitis)

ESCMID @escmid.bsky.social · Jun 22

📰 If you are looking to publish with one of ESCMID's journals

💡Did you know: Our publisher, Elsevier, holds agreements w/ selected academic institutions that could make you eligible for waiving open access fees...meaning you could publish for free.

Learn more: www.elsevier.com/ope...

#IDSky

Open access agreements | Elsevier

Elsevier has reached open access agreements with several institutions. See the full list.

www.elsevier.com

1 1

Reposted by ESGVH (ESCMID Study Group for Viral Hepatitis)

ESCMID @escmid.bsky.social · Jun 25

⌛Last chance to apply for attendance grants for the postgraduate course on 'Better methods'. Apply by 30 June!

🗓️ Athens, Greece, 28-30 Oct 🍂
💡More info: ow.ly/7mnN50VWeUy

#IDSky #clinmicro #MedSky

3 1

Reposted by ESGVH (ESCMID Study Group for Viral Hepatitis)

Ecraid @ecraid.bsky.social · Jun 18

#DKY that in our post-grad course you can choose between two tracks, join parallel workshops, discuss real-world cases, & network with your peers? 💡

👀Check out the programme, apply for an attendance grant, or register directly to secure your place!

➡️ bit.ly/44a1tdn

#IDSky #ResearchSky #Education

1 1 2

Reposted by ESGVH (ESCMID Study Group for Viral Hepatitis)

Ecraid @ecraid.bsky.social · Jun 13

Proud of our partners at University of Geneva for having published an ECRAID-Base article investigating additional analysis methods for the novel Personalised Randomised Controlled Trial (PRACTical) design in @springernature.com:

👉 www.ecraid.eu/projects/ecr...

1 2

Reposted by ESGVH (ESCMID Study Group for Viral Hepatitis)

Oana Sandulescu @oana-sandulescu.bsky.social · Jun 12

Grateful to our exceptional course faculty for their insight and dedication - a truly collaborative effort driving better outcomes for people living with HIV 🌍

@tristanjbarber.bsky.social
@ancastreinucercel.bsky.social
@eacsociety.bsky.social
@esgvh.bsky.social
@escmid.bsky.social

1 1 3

Reposted by ESGVH (ESCMID Study Group for Viral Hepatitis)

Oana Sandulescu @oana-sandulescu.bsky.social · Jun 12

We translated science 🔬 into care 🩺, learning to apply emerging evidence to real-world settings.

We explored proactive strategies for early diagnosis, and we had compelling discussions on patient-centered care, grounding our knowledge in empathy for patient needs.

Post 2/3

1 1 2

Reposted by ESGVH (ESCMID Study Group for Viral Hepatitis)

Oana Sandulescu @oana-sandulescu.bsky.social · Jun 12

Looking back on two incredible days at the HIV Advanced Training Forum 🇷🇴 - truly enriching experience alongside brilliant colleagues.

We journeyed through the complexities and nuances of HIV management, setting the foundation for responsive and relevant care.

#MedicalEducation #HIVCare

Post 1/3

1 2 2

Reposted by ESGVH (ESCMID Study Group for Viral Hepatitis)

Oana Sandulescu @oana-sandulescu.bsky.social · Jun 11

Now diving into the core of individualized HIV care at the HIV Advanced Training Forum 🇷🇴

💉 Vaccination as part of comprehensive care - Oana Sandulescu
👩‍⚕️ Tailored care for women - Marta Vasylyev
💊 Strategies for treatment success in people who inject drugs - Agata Skrzat-Klapaczynska

1 2 2

Reposted by ESGVH (ESCMID Study Group for Viral Hepatitis)

Oana Sandulescu @oana-sandulescu.bsky.social · Jun 11

Such an insightful session at the 🇷🇴 HIV Advanced Training Forum 💡
Case-based, interactive learning 🧠 bridging HIV science 🔬 and patient care 🩺

Brilliantly led by Juan Ambrosioni, championed by Agata Skrzat-Klapaczynska, Marta Vasylyev, Casper Rokx and Jose Bernardino.

So many practical insights!

1 2 2